Recurrent Hyperparathyroidism Due to a Novel CDC73 Splice Mutation
dc.contributor.author | Hattangady, Namita Ganesh | |
dc.contributor.author | Wilson, Tremika Le‐shan | |
dc.contributor.author | Miller, Barbra Sue | |
dc.contributor.author | Lerario, Antonio Marcondes | |
dc.contributor.author | Giordano, Thomas James | |
dc.contributor.author | Choksi, Palak | |
dc.contributor.author | Else, Tobias | |
dc.date.accessioned | 2017-10-05T18:18:05Z | |
dc.date.available | 2018-11-01T16:42:00Z | en |
dc.date.issued | 2017-08 | |
dc.identifier.citation | Hattangady, Namita Ganesh; Wilson, Tremika Le‐shan ; Miller, Barbra Sue; Lerario, Antonio Marcondes; Giordano, Thomas James; Choksi, Palak; Else, Tobias (2017). "Recurrent Hyperparathyroidism Due to a Novel CDC73 Splice Mutation." Journal of Bone and Mineral Research 32(8): 1640-1643. | |
dc.identifier.issn | 0884-0431 | |
dc.identifier.issn | 1523-4681 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/138298 | |
dc.description.abstract | The recognition of hereditary causes of primary hyperparathyroidism (pHPT) is important because clinical care and surveillance differ significantly between sporadic and hereditary pHPT. In addition, the increasing number of genetic tests poses a challenge to classify mutations as benign or pathogenic. Functional workâ up of variants remains a mainstay to provide evidence for pathogenicity. We describe a 52â yearâ old male patient with recurrent pHPT since age 35 years. Despite several neck surgeries with complete parathyroidectomy, he experienced persistent pHPT, necessitating repeated surgery for a forearm autotransplant, which finally resulted in unmeasurable parathyroid hormone (PTH) levels. Genetic testing revealed a new CDC73 variant (c.238â 8G>A [IVS2â 8G>A]), initially classified as a variant of uncertain significance. Parathyroid tissue from the initial surgeries showed loss of heterozygosity. Using an RTâ PCR approach, we show that the mutation leads to the use of a cryptic splice site in peripheral mononuclear cells. In addition, a minigene approach confirms the use of the cryptic splice site in a heterologous cell system. The novel c.238â 8G>A CDC73 variant activates a cryptic splice site, and the functional data provided justify the classification as a likely pathogenic variant. Our results underscore the importance of functional workâ up for variant classification in the absence of other available data, such as presence in diseaseâ specific databases, other syndromic clinical findings, or family history. In addition, the presented case exemplifies the importance to consider a hereditary condition in young patients with pHPT, particularly those with multiâ gland involvement. © 2017 American Society for Bone and Mineral Research. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | HYPERPARATHYROIDISM | |
dc.subject.other | PARAFIBROMIN | |
dc.subject.other | CDC73 | |
dc.subject.other | SPLICE MUTATION | |
dc.title | Recurrent Hyperparathyroidism Due to a Novel CDC73 Splice Mutation | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Internal Medicine and Specialities | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/138298/1/jbmr3149.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/138298/2/jbmr3149_am.pdf | |
dc.identifier.doi | 10.1002/jbmr.3149 | |
dc.identifier.source | Journal of Bone and Mineral Research | |
dc.identifier.citedreference | Carling T. Molecular pathology of parathyroid tumors. Trends Endocrinol Metab. 2001; 12 ( 2 ): 53 â 8. | |
dc.identifier.citedreference | Otto EA, Ramaswami G, Janssen S, et al. Mutation analysis of 18 nephronophthisis associated ciliopathy disease genes using a DNA pooling and next generation sequencing strategy. J Med Genet. 2011; 48 ( 2 ): 105 â 16. | |
dc.identifier.citedreference | Bricaire L, Odou MF, Cardotâ Bauters C, et al. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2013; 98 ( 2 ): E403 â 8. | |
dc.identifier.citedreference | Masi G, Iacobone M, Sinigaglia A, et al. Characterization of a new CDC73 missense mutation that impairs Parafibromin expression and nucleolar localization. PLoS One. 2014; 9 ( 5): e97994. | |
dc.identifier.citedreference | Rekik N, Ben Naceur B, Mnif M, et al. Hyperparathyroidismâ jaw tumor syndrome: a case report. Ann Endocrinol (Paris). 2010; 71 ( 2 ): 121 â 6. | |
dc.identifier.citedreference | Westin G, Bjorklund P, Akerstrom G. Molecular genetics of parathyroid disease. World J Surg. 2009; 33 ( 11 ): 2224 â 33. | |
dc.identifier.citedreference | Starker LF, Akerstrom T, Long WD, et al. Frequent germâ line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically nonâ familial primary hyperparathyroidism. Horm Cancer. 2012; 3 ( 1â 2 ): 44 â 51. | |
dc.identifier.citedreference | Duan K, Gomez Hernandez K, Mete O. Clinicopathological correlates of hyperparathyroidism. J Clin Pathol. 2015; 68 ( 10 ): 771 â 87. | |
dc.identifier.citedreference | Mehta A, Patel D, Rosenberg A, et al. Hyperparathyroidismâ jaw tumor syndrome: results of operative management. Surgery. 2014; 156 ( 6 ): 1315 â 24; discussion 24â 5. | |
dc.identifier.citedreference | Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17 ( 5 ): 405 â 24. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.